237 related articles for article (PubMed ID: 28286897)
41. Screening of the 17p11.2--p12 region in a large cohort of patients with Charcot-Marie-Tooth (CMT) disease or hereditary neuropathy with liability to pressure palsies (HNPP).
Kabzinska D; Pierscinska J; Kochanski A
J Appl Genet; 2009; 50(3):283-8. PubMed ID: 19638685
[TBL] [Abstract][Full Text] [Related]
42. [Experience in molecular diagnostic in hereditary neuropathies in a pediatric tertiary hospital].
Fernández-Ramos JA; López-Laso E; Camino-León R; Gascón-Jiménez FJ; Jiménez-González MD
Rev Neurol; 2015 Dec; 61(11):490-8. PubMed ID: 26602803
[TBL] [Abstract][Full Text] [Related]
43. Genetic evaluation of inherited motor/sensory neuropathy.
Chance PF
Suppl Clin Neurophysiol; 2004; 57():228-42. PubMed ID: 16106622
[TBL] [Abstract][Full Text] [Related]
44. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.
Hattori N; Yamamoto M; Yoshihara T; Koike H; Nakagawa M; Yoshikawa H; Ohnishi A; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakashima K; Kira J; Kaji R; Oka N; Sobue G;
Brain; 2003 Jan; 126(Pt 1):134-51. PubMed ID: 12477701
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic algorithms in Charcot-Marie-Tooth neuropathies: experiences from a German genetic laboratory on the basis of 1206 index patients.
Rudnik-Schöneborn S; Tölle D; Senderek J; Eggermann K; Elbracht M; Kornak U; von der Hagen M; Kirschner J; Leube B; Müller-Felber W; Schara U; von Au K; Wieczorek D; Bußmann C; Zerres K
Clin Genet; 2016 Jan; 89(1):34-43. PubMed ID: 25850958
[TBL] [Abstract][Full Text] [Related]
46. Peripheral Myelin Protein 22 Gene Mutations in Charcot-Marie-Tooth Disease Type 1E Patients.
Jung NY; Kwon HM; Nam DE; Tamanna N; Lee AJ; Kim SB; Choi BO; Chung KW
Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886002
[TBL] [Abstract][Full Text] [Related]
47. Mutation analysis of the PMP22, MPZ, EGR2, LITAF, and GJB1 genes in Korean patients with Charcot-Marie-Tooth neuropathy type 1.
Park HK; Kim BJ; Sung DH; Ki CS; Kim JW
Clin Genet; 2006 Sep; 70(3):253-6. PubMed ID: 16922730
[No Abstract] [Full Text] [Related]
48. [PCR in the gene diagnosis of Charcot-Marie-Tooth disease].
Xiao J; Tang B; Xia J
Zhonghua Yi Xue Za Zhi; 2001 Feb; 81(3):138-41. PubMed ID: 11798863
[TBL] [Abstract][Full Text] [Related]
49. The role of combined SNV and CNV burden in patients with distal symmetric polyneuropathy.
Pehlivan D; Beck CR; Okamoto Y; Harel T; Akdemir ZH; Jhangiani SN; Withers MA; Goksungur MT; Carvalho CM; Czesnik D; Gonzaga-Jauregui C; Wiszniewski W; Muzny DM; Gibbs RA; Rautenstrauss B; Sereda MW; Lupski JR
Genet Med; 2016 May; 18(5):443-51. PubMed ID: 26378787
[TBL] [Abstract][Full Text] [Related]
50. Screening of the early growth response 2 gene in Japanese patients with Charcot-Marie-Tooth disease type 1.
Numakura C; Shirahata E; Yamashita S; Kanai M; Kijima K; Matsuki T; Hayasaka K
J Neurol Sci; 2003 Jun; 210(1-2):61-4. PubMed ID: 12736090
[TBL] [Abstract][Full Text] [Related]
51. Genotypic and phenotypic spectrum of the most common causative genes of Charcot-Marie-Tooth disease in Hungarian patients.
Milley GM; Varga ET; Grosz Z; Nemes C; Arányi Z; Boczán J; Diószeghy P; Molnár MJ; Gál A
Neuromuscul Disord; 2018 Jan; 28(1):38-43. PubMed ID: 29174527
[TBL] [Abstract][Full Text] [Related]
52. [Mutations in the mitofusin 2 gene are the most common cause of Charcot-Marie-Tooth type 2 disease].
Sołtysińska E; Kabzińska D; Kochański A
Neurol Neurochir Pol; 2007; 41(4):350-4. PubMed ID: 17874344
[TBL] [Abstract][Full Text] [Related]
53. Molecular basis of hereditary neuropathies.
Chance PF
Phys Med Rehabil Clin N Am; 2001 May; 12(2):277-91. PubMed ID: 11345007
[TBL] [Abstract][Full Text] [Related]
54. Molecular genetics of Charcot-Marie-Tooth disease and related neuropathies.
Chance PF; Fischbeck KH
Hum Mol Genet; 1994; 3 Spec No():1503-7. PubMed ID: 7849745
[TBL] [Abstract][Full Text] [Related]
55. PMP22-Related neuropathies and other clinical manifestations in Chinese han patients with charcot-marie-tooth disease type 1.
Zhan Y; Zi X; Hu Z; Peng Y; Wu L; Li X; Jiang M; Liu L; Xie Y; Xia K; Tang B; Zhang R
Muscle Nerve; 2015 Jul; 52(1):69-75. PubMed ID: 25522693
[TBL] [Abstract][Full Text] [Related]
56. Molecular diagnosis and clinical onset of Charcot-Marie-Tooth disease in Japan.
Abe A; Numakura C; Kijima K; Hayashi M; Hashimoto T; Hayasaka K
J Hum Genet; 2011 May; 56(5):364-8. PubMed ID: 21326314
[TBL] [Abstract][Full Text] [Related]
57. Inherited peripheral neuropathy.
Keller MP; Chance PF
Semin Neurol; 1999; 19(4):353-62. PubMed ID: 10716658
[TBL] [Abstract][Full Text] [Related]
58. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.
Niemann A; Berger P; Suter U
Neuromolecular Med; 2006; 8(1-2):217-42. PubMed ID: 16775378
[TBL] [Abstract][Full Text] [Related]
59. Mutation frequency for Charcot-Marie-Tooth disease type 1 in the Chinese population is similar to that in the global ethnic patients.
Song S; Zhang Y; Chen B; Zhang Y; Wang M; Wang Y; Yan M; Zou J; Huang Y; Zhong N
Genet Med; 2006 Aug; 8(8):532-5. PubMed ID: 16912585
[TBL] [Abstract][Full Text] [Related]
60. Gap junction beta 1 (GJB1) gene mutations in Italian patients with X-linked Charcot-Marie-Tooth disease.
Mandich P; Grandis M; Geroldi A; Acquaviva M; Varese A; Gulli R; Ciotti P; Bellone E
J Hum Genet; 2008; 53(6):529-533. PubMed ID: 18379723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
